Genomics

Dataset Information

Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease


ABSTRACT: Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease

PROVIDER: PRJNA1149701 | ENA |

REPOSITORIES: ENA